Free Trial

Royalty Pharma (RPRX) SEC Filings & 10K Form

Royalty Pharma logo
$32.31 +0.02 (+0.06%)
As of 03:43 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Royalty Pharma SEC Filings

DateFilerForm TypeView
04/11/2025
8:15 AM
Royalty Pharma (Filer)
Form DEFA14A
04/11/2025
7:45 AM
Royalty Pharma (Filer)
Form DEFM14A
04/11/2025
7:50 AM
Royalty Pharma (Filer)
Form ARS
04/11/2025
7:53 AM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2025
3:17 PM
Royalty Pharma (Filer)
Form DEFA14A
04/10/2025
3:06 PM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2025
4:45 PM
Fernandez Henry A (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
4:46 PM
Bassler Bonnie L (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
4:25 PM
Royalty Pharma (Filer)
Form DEFA14A
02/21/2025
3:30 PM
Royalty Pharma (Subject)
Severgnini Achille G. (Filed by)
Form SCHEDULE 13D/A
02/13/2025
5:03 AM
Royalty Pharma (Filer)
Form PREM14A
02/12/2025
8:30 AM
FMR LLC (Filed by)
Royalty Pharma (Subject)
Form SCHEDULE 13G/A
02/11/2025
6:38 AM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/17/2025
4:12 PM
Royalty Pharma (Filer)
Form DEFA14A
01/16/2025
4:15 PM
Royalty Pharma (Filer)
Form DEFA14A
01/15/2025
4:04 PM
Royalty Pharma (Subject)
Form 425
01/13/2025
7:40 AM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
7:42 AM
Royalty Pharma (Filer)
Form DEFA14A
01/10/2025
4:21 PM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
4:26 PM
Royalty Pharma (Filer)
Form DEFA14A
01/10/2025
6:47 AM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/31/2024
3:05 PM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
2:15 PM
MORGAN STANLEY (Filed by)
Royalty Pharma (Subject)
Form SC 13G/A
11/06/2024
8:24 AM
Royalty Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
6:35 AM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
4:07 PM
Fernandez Henry A (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
4:08 PM
Bassler Bonnie L (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2024
7:39 AM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
6:17 PM
Royalty Pharma (Issuer)
Urist Marshall (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
6:19 PM
Lloyd George W. (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
6:20 PM
Coyne Terrance P. (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
8:02 AM
Royalty Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
6:20 AM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
6:04 AM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2024
3:30 PM
Royalty Pharma (Subject)
Severgnini Achille G. (Filed by)
Form SC 13D/A
06/28/2024
4:09 PM
Bassler Bonnie L (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2024
4:12 PM
Fernandez Henry A (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
7:03 AM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2024
3:16 PM
LOVE TED W (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:21 PM
Norden Gregory (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
4:06 PM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Feds Just Admitted It—They Can Take Your Cash (Ad)

The Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money isn't legally yours. Now, think your savings are safe? Think again.

Click here to get the 3 secret strategies you can put in place starting today
06/03/2024
8:13 AM
Royalty Pharma Holdings Ltd. (Filer)
Royalty Pharma (Filer)
Form 424B5
06/03/2024
7:39 AM
Royalty Pharma Holdings Ltd. (Filer)
Royalty Pharma (Filer)
Form S-3ASR
05/29/2024
4:25 PM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2024
4:42 PM
Hite Christopher (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
8:01 AM
Royalty Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
6:17 AM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:RPRX) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners